irinotecan/инсулт

Линкът е запазен в клипборда

Изберете тип сортиране

12 резултата

Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

OBJECTIVE The efficacy of cisplatin, irinotecan, and bevacizumab was evaluated in patients with extensive-stage small-cell lung cancer (ES-SCLC). METHODS Patients with ES-SCLC received cisplatin 30 mg/m(2) and irinotecan 65 mg/m(2) on days 1 and 8 plus bevacizumab 15 mg/kg on day 1 every 21 days for

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND Phase II studies have shown that the combination of capecitabine and irinotecan (the XELIRI regimen) is active in metastatic colorectal cancer (MCRC). There are, however, no data about the use of the XELIRI regimen in the neoadjuvant treatment. METHODS Patients with unresectable

Case report on 5-fluorouracil induced cerebrovascular accident

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Introduction: 5-Fluorouracil is an antineoplastic agent generally used to treat various types of solid tumors. The common adverse drug reaction associated with 5-fluorouracil are myelosuppression, mucositis, diarrhea, and hand-foot

The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Rationale: Cancer-related stroke has been regarded as an emerging subtype of ischemic event. Acute treatment for this subtype may include the antiplatelet agents, anticoagulants, or endovascular intervention.

A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация

BACKGROUND The objectives of the current study were to evaluate the safety and efficacy of gemcitabine and irinotecan (Irinogem) in patients with metastatic bladder cancer. Irinotecan and gemcitabine are newer-generation chemotherapeutic agents with different mechanisms of action, nonoverlapping

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация

OBJECTIVE Recurrent grade III-IV gliomas have a dismal prognosis with minimal improvements in survival seen following currently available salvage therapy. This study was conducted to determine if the combination of a novel antiangiogenic therapy, bevacizumab, and a cytotoxic agent, irinotecan, is

FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация

FOLFIRINOX is a standard chemotherapeutic regimen for patients with advanced pancreatic cancer who have a good performance status. In this study, we present the case of a 64-year-old male who developed dysarthria following FOLFIRINOX treatment, and review all four cases of dysarthria encountered

Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация

OBJECTIVE Preclinical data indicate there is strong synergism of action against Ewing sarcoma in sequential treatment with trabectedin followed by irinotecan and it appears to be related to a selective blockade of the transcription factor EWS-FLI1. This combination was evaluated in Ewing sarcoma

Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация

OBJECTIVE Clinical trials have shown that adding bevacizumab to cytotoxic chemotherapy improves survival for patients with colorectal cancer, although its effectiveness in the Medicare population is uncertain. METHODS Using the Surveillance, Epidemiology, and End Results (SEER) -Medicare linked

[Cases of three patients undergoing chemotherapy for gastric cancer who developed Trousseau's syndrome].
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация

Trousseau's syndrome involves unexplained thrombotic events along with malignancy. We report the cases of 3 patients undergoing chemotherapy for gastric cancer in whom Trousseau's syndrome occurred. Case 1 involved a 43-year-old woman undergoing S-1/cisplatin( CDDP) combination therapy as first-line

Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация

Aflibercept in combination with 5‑fluorouracil (5‑FU)/irinotecan improves overall survival in the second‑line therapy of patients with metastatic colorectal cancer (mCRC). In this study, we evaluated the effects of aflibercept in first‑line therapy with FOLFOX followed by maintenance with

Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация

The roots of Salvia miltiorrhiza ("Danshen") are used in traditional Chinese medicine for the treatment of numerous ailments including cardiovascular disease, hypertension, and ischemic stroke. Extracts of S. miltiorrhiza roots in the formulation "Compound Danshen Dripping Pill" are undergoing

Присъединете се към нашата
страница във facebook
Herbal & Natural Medicine
Най-пълната база данни за лечебни билки, подкрепена от науката
Работи на 55 езика
Билкови лекове, подкрепени от науката
Разпознаване на билки по изображение
Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
Прочетете научни публикации, свързани с вашето търсене
Търсете лечебни билки по техните ефекти
Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите
Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

irinotecan/инсулт

Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study.

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial.

Case report on 5-fluorouracil induced cerebrovascular accident

The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report

A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer.

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases.

Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.

Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.

[Cases of three patients undergoing chemotherapy for gastric cancer who developed Trousseau's syndrome].

Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.

Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

Най-пълната база данни за лечебни билки, подкрепена от науката